Vanda Pharmaceuticals Inc. said Friday that James Patrick Kelly will become its chief financial officer, treasurer, and secretary.
Kelly will join Vanda on Dec. 13. Since 2006, he has held a series of finance positions at MedImmune LLC, and before that he worked at Aetna Inc. and Biogen Idec Inc.
Vanda has not had a permanent CFO since January 2009, when Steven Shallcross stepped down as part of a series of job cuts. Stephanie Irish was the company's acting CFO from January 2009 until August 2010. Since then, the job has been handled by President and CEO Mihael Polymeropoulos.